Restricted accessLetterFirst published online 2017-3
Systemic lupus erythematosus with ADAMTS13 inhibitor-negative thrombotic microangiopathy treated with combination of mycophenolate mofetil,plasma exchange and steroid
LansiganFIsufiITagoeCE. Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: The role of ADAMTS13. Rheumatology2011; 50: 824–829.
2.
CacoubNLGuichardDSIPietteJC. Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Lupus2008; 17: 69–71.
3.
RiegerMMannucciPMKremer HovingaJA. ADAMTS13 autoantibodies in patients with thrombotic microangiopathy and other immunomediated diseases. Blood2005; 106: 1262–1267.
4.
NodaSOguraMTsutsumiA. Thrombotic microangiopathy due to multiple autoantibodies related to antiphospholipid syndrome. Pediatr Nephrol2012; 27: 681–685.
